Success Stories: North America Immigration Law Group Supported an Associate Research Scientist from Taiwan to Secure EB-2 NIW Petition Approval in Just 6 Months

 

Client’s Testimonial:

“Thank you very much. It's been great working with you.”


On March 18th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for an Associate Research Scientist in the Field of Biomedical Science (Approval Notice).


General Field: Biomedical Science

Position at the Time of Case Filing: Associate Research Scientist

Country of Origin: Taiwan

State of Residence at the Time of Filing: New York

Approval Notice Date: March 18th, 2021

Processing Time: 6 months


Case Summary:

An I-140 NIW (National Interest Waiver) petition approval was granted to an associate research scientist from Taiwan in just 6 months. When our client approached us, we started reviewing his credentials as part of legal services before taking his case. Once we were through with the evaluation, we confirmed that he was a suitable candidate for the EB-2 visa category and arranged an array of important details to be documented in his petition packet. We consolidated the following information in our presentation:

  • We noted that he held a Ph.D. in structural biology and biochemistry with substantial years of experience researching the field of biomedical science. His proposed research focuses on utilizing electron microscopy to uncover the biological processes behind diverse diseases such as cancer, pneumonia, and kidney disease. Our major motive was to prove the great importance of his research by emphasizing the fact that it dramatically improves the understanding of diseases that have a genetic or translational origin, such as Parkinson’s disease, polycystic kidney disease, and cancer. His findings are essential for developing treatments and cures for diseases that have an origin in genetic mutations while lowering the expenses associated with treating these conditions. Thus, his continued presence in the U.S. is exceedingly valuable.
  • We also detailed the 7 peer-reviewed journal articles (3 of them first-authored) he published, which accumulated 265 citations, illustrating his key role in advancing biomedical science research. We observed that many other well-known scientists have used our client’s research to further their investigations and developments, signifying the immense utility of his contributions to the field. The frequent implementation of our client’s methods also shows that his research must be continued unhindered.
  • Besides, we included five recommendation letters in his petition packet to further highlight the usage of his work which has a solid impact upon the biomedical science field as a whole. The fellow experts contributed the following statements corroborating the aforementioned facts:

“[Client’s] research into revealing the underlying causes of diseases addresses the millions of people worldwide who are affected by cancer...This research is absolutely integral to developing targeted drug delivery systems, as he has shown how these growth factors communicate and function in the body long before a tumor becomes visible to a physician or the naked eye. For this reason, his research must be allowed to continue, as he provides medical solutions to one of the world's most dangerous diseases.”

&

“With that research, he offers paths towards vaccinations and therapies that lift the burden of disease in the United States and alleviate healthcare costs that are associated with both chronic and acute illnesses. Permitting [client] to continue working on identifying disease origins and the methods of their pathology in the body is therefore of intense national interest.”

The USCIS thoroughly adjudicated our client’s I-140 petition, and successfully, he was granted the EB-2 NIW approval, special thanks to our associated team. We are pleased to lead our client one step closer to green card success and sincerely thank him for trusting our law firm for his NIW application.